Literature DB >> 12839269

Endothelin-1 in atherosclerosis and other vasculopathies.

Nicolas Bousette1, Adel Giaid.   

Abstract

Atherosclerosis is a major risk factor for both myocardial infarction and stroke. A key aspect of this disease is the imbalance of vasoactive factors. In this concise review, we focus on the role of endothelin-1 in the atherosclerotic process and other vasculopathies. Previously, we have demonstrated that there is a correlation between the expression of endothelin and the underlying atherosclerotic lesion. Immunoreactivity was observed for both ET-1 and ECE-1 in endothelial cells, smooth muscle cells, and macrophages within lesions. Endothelin's role in atherosclerosis must extend from its varying physiological activities, including vasoconstriction, mitogenesis, neutrophil adhesion, and platelet aggregation, and hypertrophy, as well as its propensity to induce the formation of reactive oxygen species. We also discuss regulation of endothelin by angiotensin II, reactive oxygen species, thrombin, aging, and LDL in the cardiovascular system. Finally, we demonstrate the role of endothelin in pulmonary hypertension and transplant associated vasculopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12839269     DOI: 10.1139/y03-010

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  13 in total

1.  Differential roles of endothelin-1 in angiotensin II-induced atherosclerosis and aortic aneurysms in apolipoprotein E-null mice.

Authors:  Renée S Suen; Sarah N Rampersad; Duncan J Stewart; David W Courtman
Journal:  Am J Pathol       Date:  2011-06-29       Impact factor: 4.307

2.  Arrestins 2 and 3 differentially regulate ETA and P2Y2 receptor-mediated cell signaling and migration in arterial smooth muscle.

Authors:  Gavin E Morris; Carl P Nelson; Paul J Brighton; Nicholas B Standen; R A John Challiss; Jonathon M Willets
Journal:  Am J Physiol Cell Physiol       Date:  2011-12-07       Impact factor: 4.249

Review 3.  Endothelin in health and disease.

Authors:  Emina Nakas-Ićindić; Asija Zaciragić; Almira Hadzović; Nesina Avdagić
Journal:  Bosn J Basic Med Sci       Date:  2004-07       Impact factor: 3.363

4.  Improvement of postischemic hepatic microcirculation after endothelinA receptor blockade--endothelin antagonism influences platelet-endothelium interactions.

Authors:  Dirk Uhlmann; Sebastian Glasser; Gabor Gaebel; Barbara Armann; Stefan Ludwig; Andrea Tannapfel; Johann Hauss; Helmut Witzigmann
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

Review 5.  Epidemiology of cardiovascular disease in type 2 diabetes: the Indian scenario.

Authors:  Viswanathan Mohan; Janarthanan Vijay Venkatraman; Rajendra Pradeepa
Journal:  J Diabetes Sci Technol       Date:  2010-01-01

6.  Phytoestrogen alpha-zearalanol antagonizes oxidized LDL-induced inhibition of nitric oxide production and stimulation of endothelin-1 release in human umbilical vein endothelial cells.

Authors:  Hai-Shan Xu; Jinhong Duan; Shunling Dai; Yunqing Wu; Renyu Sun; Jun Ren
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

7.  The association of endothelin-1 gene polymorphism and its plasma levels with hypertension and coronary atherosclerosis.

Authors:  Nazanin Ebrahimi; Gholamreza Asadikaram; Abbas Mohammadi; Yunes Jahani; Mina Moridi; Mohammad Masoumi
Journal:  Arch Med Sci       Date:  2019-07-22       Impact factor: 3.318

8.  Modulatory Role of Nitric Oxide/cGMP System in Endothelin-1-Induced Signaling Responses in Vascular Smooth Muscle Cells.

Authors:  Georgia Kapakos; Ali Bouallegue; Grace Bou Daou; Ashok K Srivastava
Journal:  Curr Cardiol Rev       Date:  2010-11

Review 9.  The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications.

Authors:  Stéphanie Dal; Séverine Sigrist
Journal:  Diseases       Date:  2016-07-11

10.  Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2.

Authors:  Gavin E Morris; Carl P Nelson; Nicholas B Standen; R A John Challiss; Jonathon M Willets
Journal:  Cardiovasc Res       Date:  2009-09-11       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.